Search

Dr. Heng presented a talk, "Using miRNA profiling technologies to assess breast cancer patient response to platinum-based chemotherapy" at the 2023 Harvard Institute for RNA Medicine / MiRXES workshop. https://www.linkedin.com/feed/update/urn:li:activity:7060326293812219904?utm_source=share&utm...

Dr. Heng hosted Dr. Vikrant Kumar, Head of Bioinformatics at Mirxes, for a Harvard Institute of RNA Medicine (HiRM) RNA technologies showcase. Dr. Kumar's talk was about spatially resolved sub-cellular transcriptomics (Stereo-seq) and its applications. How advances in generating high resolution...

Dr Heng was invited by NCI Center to Reduce Cancer Health Disparities (CRCHD) to share her story about the moment that inspired her to work in transgender cancer research. https://twitter.com/NCICRCHD/status/1665818273626353666?s=20

NCI Division of Cancer Biology (DCB) highlighted Dr. Heng's DCB-supported breast cancer research on Twitter/X for Breast Cancer Awareness in October. https://x.com/NCICancerBio/status/1717988909551071461?s=20

Transgender Breast Care Working Group, led by Dr. Heng was nominated for the 2023 Group/Program Diversity Award given by Harvard Medical School. Although HMS is unable to honor each nominee with an award, HMS believes that being nominated is an honor unto itself and hope that the team will continue...